Kunpeng Gene (Beijing) Scientific Instruments Co.

What Kunpeng Gene (Beijing) Scientific Instruments Co. does

Kunpeng Gene (Beijing) Scientific Instruments Co. (鲲鹏基因) is a Chinese molecular diagnostics instrumentation company founded in 2016 in Beijing that designs and manufactures real-time PCR systems, portable/POCT qPCR systems, nucleic acid extractors, gradient PCR cyclers, liquid handling workstations, and associated lyophilized reagents and consumables. Its technology stack rests on self-developed core components including sonic phase-change temperature control, time-resolved scanning optics, microfluidic single-use cartridges, and lyophilized reagent formulations, with a proprietary Suzhen (溯真) data analysis algorithm and ArchiSign software supporting 21 CFR Part 11-compliant workflows. The company sells to clinical diagnostics hospitals, life-science research labs, agricultural and seed-industry QC, veterinary diagnostics, public-health surveillance, customs, and biopharmaceutical 3Q services customers, with products deployed in 30+ Chinese provinces and 70+ countries via a hybrid direct and 300+ partner distributor model.

The business model combines one-time instrument placement with multi-year recurring reagent and consumable pull-through. Instruments (Archimed series, iFIND POCT, ArchiCycler, ArchiPure, RocStation) ship at the 10,000+ cumulative unit scale against a 50,000-unit annual production capacity, and closed-loop proprietary cartridges plus lyophilized reagents lock in switching costs on each installed base. Revenue is generated through direct sales to hospitals, CDCs, customs, and biopharma, distribution partnerships including Sinopharm Gene for state-channel coverage, and export through global partners. Regulatory clearances span NMPA Class III (iFIND, Archimed X Pro), CE-IVD, UKCA, and FDA, and the company co-drafted the GB/T 42753-2023 national standard for real-time PCR instruments, giving it standards-level influence in the Chinese molecular diagnostics market.

The competitive positioning is a low-cost, full-stack domestic alternative to imported brands such as Roche, Thermo Fisher, and Bio-Rad, with management citing 30-50% cost savings versus imports as a key purchasing lever. The company is funded by professional medical investors including Anhui Kunhua Fund and Taiping Medical and Health Fund, supports a 200+ R&D headcount with 3%+ PhDs, and operates from 10,000+ m² of R&D and GMP manufacturing space across Beijing (with a dedicated Changping building) and a Wuhan regional subsidiary.

Name

Kunpeng Gene (Beijing) Scientific Instruments Co.

Legal name

鲲鹏基因（北京）科学仪器有限公司

Website

https://rocgene.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

101–250 employees

Short description

Kunpeng Gene (Beijing) Scientific Instruments Co. (鲲鹏基因) is a Chinese molecular diagnostics company founded in 2016 that develops real-time PCR instruments, POCT systems, reagents, and software, serving clinical diagnostics, life-science research, agriculture, veterinary, public health, customs, and biopharmaceutical customers across China and 70+ overseas markets.

Ownership category

akta.pro rank

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Instrument hardware sales: Sales of proprietary molecular diagnostic instruments including ArchiPure 16/32/96/96 Pro automated nucleic acid extractors, Archimed series qPCR instruments (X4/X6/X Pro/R/Mini/Mini Pro/M/J), ArchiCycler gradient PCR, iFIND fully-automated POCT system, ArchiSuit portable testing suitcase, RocStation liquid handling system, and Archimed M automated PCR module. Hardware is sold as units to end customers and channel partners; cumulative instrument sales exceeded 10,000 units (as referenced in milestones).
2. Reagent and consumables sales: Sales of nucleic acid extraction reagents, qPCR pre-mixes (probe-based, dye-based, one-step RT-qPCR), pathogen detection kits (human pathogens, biopharma host residual DNA kits, mycoplasma kits, veterinary/pet diagnostic kits), and proprietary lyophilized reagent cartridges for the iFIND POCT system. Reagents are typically recurring and tied to installed instrument base.
3. Biopharma solution packages and 3Q services: For biopharma customers, Rocgene offers end-to-end solutions bundling ArchiPure extractors + Archimed X-series instruments + ArchiSign audit-trail software + 3Q (IQ/OQ/PQ) qualification services compliant with FDA 21 CFR Part 11 and China NMPA drug-record requirements. 3Q services and audit-trail compliance generate professional-services revenue.
4. Software licensing and LIS integration: Archimed Analyzer software supports export in *.csv and *.Json array formats for LIS system integration. Software is bundled with instruments but customization (e.g., custom report-generation, on-demand algorithm development such as SNP analysis with adjustable interpretation thresholds) represents incremental professional-services revenue.
5. iFIND closed-cartridge POCT consumables: iFIND fully-automated POCT system uses proprietary injection-molded sealed cartridges with lyophilized pre-loaded reagents. Each test requires a new cartridge, generating recurring consumables revenue tied to installed iFIND base; iFIND TBR tuberculosis cartridge received Class III medical-device registration.

Pricing tiers

Go-to-market motion4 records

Distribution channels6 records

Marketing channels9 records

Core offering

Kunpeng Gene develops, manufactures, and sells an integrated molecular diagnostics platform combining proprietary Real-time PCR instruments (Archimed series), automated nucleic acid extractors (ArchiPure series), the iFIND fully-automated point-of-care molecular detection system with closed cartridges, supporting reagents, and Archimed Analyzer / ArchiSign software. The closed-loop "instrument + reagent + software + consumables" offering serves clinical diagnostics, life science research, biopharmaceutical QC, agricultural/seed testing, animal/veterinary disease detection, and public health / CDC applications.

Product overview

Kunpeng Gene (Beijing) Scientific Instruments Co., Ltd. delivers an integrated molecular diagnostics platform built on a 'Molecular POCT Gene Detection Solution + Laboratory Gene Detection Solution' architecture, combining proprietary instruments, reagents, consumables, and software into closed-loop workflows. The core POCT platform centers on the iFIND® Fully Automated Nucleic Acid Detection Analysis System paired with closed-system disposable cartridges, while the laboratory segment includes the ArchiPure series of automated nucleic acid extractors (16/32/96/96 Pro), Archimed series fluorescent quantitative PCR instruments (X4/X6/X Pro, R4/R6, 384, Mini 16/Mini Pro, M), ArchiCycler gradient PCR instruments, ArchiSuit portable mobile detection kits, RocStation automated liquid handling systems, and Atlas 120 open workstations. These instruments are complemented by an extensive reagent portfolio including qPCR pre-mixes, human pathogen detection kits, biopharmaceutical host residual DNA and mycoplasma detection kits, livestock and pet diagnostic kits, and magnetic bead-based nucleic acid extraction kits, all managed by the Archimed Analyzer and ArchiSign audit trail software for full data integrity compliance.

Differentiator

Problem solved

Functional benefit

Brands

• Archimed: Flagship time-resolved real-time fluorescent quantitative PCR instrument family (models X4, X6, X Pro, R4/R6, 384, Mini 16/Mini Pro/Mini J) using Fresnel-lens-based optical signal acquisition and proprietary time-resolved signal separation technology.
• ArchiPure
• iFIND
• ArchiCycler
• RocStation
• Archimed M
• ArchiSuit

Products and services

• iFIND Fully Automated Nucleic Acid Detection Analysis System Fully integrated molecular POCT system delivering 'sample-in, result-out' automated gene detection in under one hour; supports tuberculosis and drug-resistance, fungal diseases, diarrheal pathogens, respiratory diseases, and pet diseases. Class III medical device registered.
• High-Throughput Unattended Fully Automated Nucleic Acid Detection Analysis System High-throughput molecular POCT system for unattended fully automated nucleic acid detection, part of the Molecular POCT Gene Detection Solution product line.
• Fully Automated Molecular Detection Cartridge (closed cartridge) Disposable integrated cartridges for the iFIND POCT platform with closed-system design, pre-packaged lyophilized reagents, and nested sealing lids to prevent contamination, enabling sample-in/result-out workflows.
• ArchiPure 16 Fully Automated Nucleic Acid Extractor Compact, portable fully automated nucleic acid extraction and purification instrument using magnetic bead method, processing 1-16 samples within 10-40 minutes; open platform compatible with most extraction kits on the market.
• ArchiPure 32 Fully Automated Nucleic Acid Extractor Automated nucleic acid extraction instrument using nano magnetic bead purification technology, processing 1-32 samples per run from whole blood, bacteria, plasmid, virus, serum-free, and plant samples.
• ArchiPure 96 Fully Automated Nucleic Acid Extractor High-throughput fully automated nucleic acid extraction and purification instrument using nano magnetic bead separation, processing 1-96 samples per run with built-in decontamination system.
• ArchiPure 96 Pro Fully Automated Nucleic Acid Extractor High-throughput fully automated nucleic acid extraction and purification instrument using nano magnetic bead separation; single batch processes up to 96 samples for high-throughput molecular testing lab needs.
• RocStation Automated Liquid Handling System Fully automated liquid handling system for PCR experiment workflow construction, integrating sample dispensing, consumable preparation, and intelligent control with auto tip loading/unloading, precision pipetting (5-200μL), and 30-second fast film sealing.
• ArchiSuit Portable Mobile Nucleic Acid Detection Kit Portable mobile nucleic acid detection box integrating Archimed Mini series portable qPCR instrument, ArchiPure 16 automated nucleic acid extractor, centrifuge, vortex mixer, pipettes and supporting reagents with long-life outdoor mobile power supply.
• ArchiCycler Intelligent Gradient PCR Instrument Intelligent gradient PCR instrument series with sonic temperature-changing technology and independent temperature zone control; supports wide-range temperature gradients, multi-module parallel operation, and 12°C/s heating/cooling rate.
• Archimed M Automated PCR Module Automated PCR module designed for automation workstations using sonic heat transfer technology; supports SiLA protocol for integration with Hamilton, PerkinElmer, Beckman, MegaRobo, Burning Rock, and Mai Di Ke automation platforms.
• Archimed Medical Fluorescent Quantitative PCR Instrument (X4/X6/X Pro) Medical-grade fluorescent quantitative PCR instrument series (X4/X6/X Pro) based on Fresnel lens optical signal acquisition and patented time-resolved signal acquisition technology; certified for clinical diagnostic applications.
• Archimed R/384 Series High-Throughput Fluorescent Quantitative PCR Instrument Archimed R series (R4/R6) and Archimed 384 high-throughput fluorescent quantitative PCR instruments with 4/5/6 fluorescence channels and 16/96/384-well capacity options for gene expression analysis, SNP genotyping, and absolute quantification.
• Archimed Mini Pro Portable Fluorescent Quantitative PCR Instrument Next-generation portable fluorescent quantitative PCR instrument featuring third-generation sonic temperature control (max ramp rate ≥11°C/s, average ≥7.5°C/s), detection limit down to 1 copy, and ultra-fast time-resolved linear scanning.
• Pathogenic Microorganism and Biopharmaceutical Nucleic Acid Extraction Kit Magnetic bead-based nucleic acid extraction kits processing whole blood, plasma, serum, throat swabs, bronchoalveolar lavage fluid, secretions, cells, and cultures; extraction efficiency >90%, compatible with PCR, qPCR, and NGS.
• qPCR Pre-Mix Series qPCR pre-mix series for high-precision fluorescent quantitative detection supporting probe method, dye method, and one-step RT-qPCR detection; enhanced anti-interference formula compatible with crude sample direct detection.
• Human Pathogen Detection Reagents Pathogen microorganism nucleic acid detection kits covering tuberculosis and rifampicin/multi-drug resistance, diarrheal pathogens (bacteria and virus), bacterial detection kits, monkeypox/COVID-19 kits, and fungal detection kits; built-in quality control system.
• Biopharmaceutical Reagents (Host Residual DNA & Mycoplasma Detection Kits) Host residual nucleic acid detection kit series for biopharma process QC, detecting CHO cells, E. coli, plasmid vectors, Vero, Pichia pastoris, HEK293, NS0, Sf9&AcMNPV, and mycoplasma; sensitivity meets biopharmaceutical safety standards.
• Livestock and Pet Diagnostic Reagents Animal and pet diagnostic reagent kits including African Swine Fever (universal and vaccine/wild strain differentiation), feline respiratory pathogens, feline ocular pathogen triple detection, feline diarrhea pathogens, and CE-certified monkeypox detection kits.
• ArchiSign Audit Trail Software Self-developed audit trail system designed to meet the 'Drug Records and Data Management Requirements (Trial)' and FDA 21 CFR Part 11 data integrity requirements; provides regulatory-compliant audit trail for biopharma users of Archimed PCR systems.
• Archimed Analyzer Software Proprietary software suite for Archimed fluorescent quantitative PCR instrument series providing experiment design, data acquisition, analysis, and LIS integration via CSV/JSON file export; supports multiple fluorescence channels and time-resolved signal separation.
• iFIND IFQ Tuberculosis Dual Drug Resistance Detection Kit Cartridge-based test for the iFIND POCT platform providing dual drug-resistance testing for tuberculosis in a single cartridge to support precision TB diagnosis and treatment.
• iFIND TBR Tuberculosis and Rifampicin Resistance Kit Cartridge-based tuberculosis and rifampicin resistance detection kit for the iFIND POCT platform; received NMPA Class III medical device registration certificate.

Quantifiable outcome

• HBV amplification time reduced from 102 min to 63 min (38% reduction); patient waiting from 48h to 12h (75% reduction); low-viral-load detection rate +30%
• +11 more outcomes

Named customers18 records

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration10 records

Feature8 records

Partnerships

15 partnerships are on record, tiered flagship — most recent major strategic partnership as of source data, core integration partner for archimed m and archimed x series, core integration partner, integration partner, domestic integration partner, multiple domestic integration partners, medium — provincial-level strategic engagement, high — government partnership enabling district-level expansion, strategic — branded as 'innovative cooperation', high — beijing government-level strategic partnership, flagship (most important strategic partner cited in corporate communications), national standards partnership — high credibility, university-industry partnership — community/kol building, cross-platform reagent validation — supports installed-base utilization and core channel reach — 30+ provinces plus international.

• Ningbo Hailer-Sign Gene (宁波海尔施基因科技股份有限公司)flagship — most recent major strategic partnership as of source dataStrategic or Co-development Partner · 31 October 2025On October 31, 2025 at the 19th Chinese Medical Association NCLM (Testing Medicine Conference), Hailer-Sign Gene (Chairman & CEO Yu Ding) and Kunpeng Gene held a strategic cooperation signing ceremony at the Shandong International Convention and Exhibition Center. The cooperation focuses on landing-deployment of molecular POCT respiratory products. Hailer-Sign Gene is strong in capillary-electrophoresis respiratory molecular detection, complementing Kunpeng's instrument/reagent strengths.
• Hamilton (自动化工作站)core integration partner for archimed m and archimed x seriesTechnology or Integration · 1 November 2023Hamilton is one of the named automated liquid-handling workstation partners that Archimed M and Archimed X series integrate with. Archimed M supports the international SiLA standard communication protocol for automated-workstation integration. Archimed M has been connected with Hamilton, PerkinElmer, Beckman, Burning Stone (燃石), 迈迪克 and others.
• PerkinElmer (PE)core integration partnerTechnology or Integration · 1 November 2023PerkinElmer is one of the named automated liquid-handling workstation partners integrated with Archimed M (SiLA-standard communication protocol) and Archimed X series ('one-to-many' control capability supports multi-instrument co-control from one PC).
• Beckman Coulter (贝克曼)integration partnerTechnology or Integration · 1 November 2023Beckman is one of the named automated liquid-handling workstation partners integrated with Archimed M for end-to-end PCR automation workflows.
• Mega Robotics (镁伽)domestic integration partnerTechnology or Integration · 1 November 2023Mega Robotics is one of the named automated liquid-handling workstation partners integrated with Archimed M (SiLA-standard communication protocol). Also integrated with Archimed X series.
• Huixiang (汇像), Hetang (荷塘), Shengxiang (圣湘), Laiboyi (徕伯益), Mingsen Bio (明森生物), Burning Stone (燃石), Maidike (迈迪克)multiple domestic integration partnersTechnology or Integration · 1 November 2023Named automated-workstation partners integrated with Archimed X series for full PCR automation. Archimed X-series supports 'one-to-many' communication protocol — a single host computer can control multiple Archimed devices in parallel, further raising detection throughput.
• Hubei Provincial Government (15th China Bio-industry Conference)medium — provincial-level strategic engagementStrategic or Co-development Partner · 10 June 2023Kunpeng Gene VP Dai Tao attended the 15th China Bio-industry Conference in Wuhan (Optics Valley), co-hosted by Hubei Provincial Government with 18 national societies and China Science & Technology Newspaper. Kunpeng signed a major project on-site; 67 key projects in total were signed with total value of RMB 39.7 billion covering innovative drugs, APIs, high-end medical devices, bio-services and health products.
• Beijing Municipal Government (2023 Beijing Investment Global Summit)high — government partnership enabling district-level expansionStrategic or Co-development Partner · 26 May 2023At the inaugural 2023 Beijing Investment Global Summit hosted by Beijing Municipal Government, Kunpeng Gene CEO Guo Qiuzhen signed on-site with Beijing Changping District Standing Deputy Governor Liu Xiaodong as a key Beijing-investment enterprise. The summit brought together World-500 and large-enterprise representatives and signed 39 major projects worth RMB 60.801 billion in total.
• Hetang Shenghua (荷塘生华)strategic — branded as 'innovative cooperation'Strategic or Co-development Partner · 1 May 2023Kunpeng Gene and Hetang Shenghua signed a strategic cooperation agreement in May 2023 — described as 'innovative cooperation.' Both organizations are part of the Beijing life-science innovation ecosystem (Hetang Shenghua is associated with Tsinghua Holdings).
• Beijing·Changping Life Science International Forum (2022)high — beijing government-level strategic partnershipStrategic or Co-development Partner · 17 November 2022Kunpeng Gene was among 26 life-science projects signed at the 2022 Beijing·Changping Life Science International Forum (co-hosted by Beijing Municipal Science & Technology Commission, Zhongguancun Administrative Committee, Beijing Changping District Government). The 26 projects collectively plan >RMB 10.8 billion in investment and >RMB 72.5 billion in cumulative 5-year revenue. Kunpeng signed as a 'medical-device mature-track' major project.
• Sinopharm Gene (中生捷诺 / China National Biotec Group Genodx)flagship (most important strategic partner cited in corporate communications)Strategic or Co-development Partner · 15 August 2022On August 15, 2022 Kunpeng Gene signed a strategic cooperation agreement with Sinopharm Gene (under China National Biotec Group / China National Pharmaceutical Group). The partners will jointly advance automated, intelligent, multi-fluorescent PCR technology in tumor-methylation early-screening and multi-target pathogen detection clinical applications. The first collaboration integrates Sinopharm Gene's recently approved '宫安丽®' cervical-cancer HPV methylation triage kit (Class I domestic first) with Kunpeng's Archimed qPCR instruments to build an 'instrument + reagent + intelligent software' tumor-methylation early-screening solution. The two parties have also collaborated during COVID-19 serving nucleic acid-testing bases in Shanghai, Beijing, Macau, and Lanzhou.
• China Inspection and Quarantine Science Research Institute; Beijing Physical and Chemical Analysis and Testing Center; China National Institute of Metrology; Shanghai Institute of Measurement and Testing Technologynational standards partnership — high credibilityStrategic or Co-development PartnerJoint drafting of national standard GB/T 42753-2023《实时荧光定量PCR仪性能评价通则》— China's first national standard for fluorescent qPCR instrument performance evaluation. Effective December 1, 2023. Led by China Inspection and Quarantine Science Research Institute, proposed by China Machinery Industry Federation, published by State Administration for Market Regulation / Standardization Administration of China.
• China University of Mining and Technology (中国矿业大学)university-industry partnership — community/kol buildingStrategic or Co-development PartnerJoint 'Fluorescent qPCR Theory and Practice' training programs (second cohort held September 14, 2022) at Kunpeng's Xuzhou intelligent manufacturing center, including theoretical instruction and lab practice covering absolute quantification (probe method / standard curve), relative quantification (SYBR Green), PCR optimization, data analysis, and high-resolution melt-curve applications. Builds next-generation user community and academic KOLs.
• ABI 7500, StepOne Plus, CFX96 (Bio-Rad) — competitor reference instruments validated as compatible with Kunpeng reagentscross-platform reagent validation — supports installed-base utilizationTechnology or IntegrationKunpeng's biopharma host-residual DNA detection reagent kits are validated as compatible with the ABI 7500, StepOne Plus, and CFX96 (Bio-Rad) qPCR instruments — not formal partnership but functional multi-instrument validation that enables Kunpeng reagents to be sold into customer labs with imported instruments.
• Domestic distributor network covering all provinces of China (代理商分布)core channel reach — 30+ provinces plus internationalChannel Partner/ Reseller/ DistributorAuthorized distributor / agent network covers Beijing, Shanghai, Guangzhou, and all 23 provinces + 5 autonomous regions of China plus Taiwan. Agents manage local sales, technical support, and after-sales service for hospitals, CDCs, third-party testing labs. Coordination via Beijing-based entity Rocgene Technology Co., Ltd. (+86 10 86229225).

Scale indicators15 records

Recent moves11 records

Expansion highlights6 records

Others

• Hamilton Company: Global leader in automated liquid-handling workstations; Archimed M integrates with Hamilton robots via the SiLA protocol. Although not a direct PCR competitor, Hamilton is an integration partner whose automation platforms co-sell with or against Kunpeng's Archimed M module in high-throughput biopharma and clinical labs.

Broad incumbents

• Bio-Rad Laboratories: Global life-science instrument leader whose CFX96 real-time PCR system is a primary incumbent in Chinese molecular diagnostics labs. Kunpeng's host-residual DNA kits are validated as compatible with CFX96, reflecting CFX96's deep installed base; both compete in clinical qPCR, biopharma QC, and research applications.
• Thermo Fisher Scientific (Applied Biosystems): Owns the Applied Biosystems QuantStudio and 7500 real-time PCR franchises, the dominant installed base in Chinese clinical and research labs. Kunpeng's biopharma kits are validated on ABI 7500 and StepOne Plus, evidencing ABI's incumbency; both compete across clinical diagnostics, biopharma, and life-science research.
• Roche Diagnostics: Operates the LightCycler real-time PCR family and the cobas LDT PCR systems, and supplies the broadest FDA-cleared IVD menu in molecular diagnostics. Competes with Kunpeng in clinical molecular diagnostics, hospital PCR workflow automation, and companion diagnostics; sets the upper bound of pricing that Kunpeng's 30-50% discount targets.
• QIAGEN: Supplies the Rotor-Gene Q real-time PCR system, the QIAcube extraction automation, and a deep menu of IVD molecular diagnostic kits. Overlaps with Kunpeng's ArchiPure extraction + Archimed qPCR workflow and biopharma QC kits, particularly in European and Asian research/diagnostic labs.
• Autobio Diagnostics: Major Chinese IVD company listed on Shanghai Stock Exchange with a growing molecular diagnostics business, including chemiluminescence immunoassay and PCR-based platforms. Competes with Kunpeng in hospital and CDC procurement for infectious-disease and clinical-chemistry testing.

Direct peers

• Sansure Biotech: Leading Chinese molecular diagnostics company listed on the Shanghai STAR Market, offering its own real-time PCR instruments and a deep pathogen detection kit portfolio (including COVID-19, HPV, HBV, STD, respiratory). Direct competitor to Kunpeng in Chinese hospital and CDC tenders for Class III molecular diagnostic kits and instruments.
• Liferiver Bio-Tech (Shanghai Liferiver): Shanghai-based molecular diagnostics company specializing in PCR-based pathogen detection kits (respiratory, diarrheal, sexually transmitted, oncology) and real-time PCR instruments. Competes with Kunpeng across Chinese clinical diagnostics, food-safety, and animal-disease testing channels.
• Vazyme Biotech: Chinese molecular diagnostics and life-science reagents company offering qPCR instruments (e.g., Q1/Q2/Q5 series) plus a deep qPCR master-mix and pathogen-detection kit catalog. Direct competitor to Kunpeng in Chinese research institutions, biotech, and clinical diagnostic labs across all application verticals.
• Daan Gene (Kingmed/Hybrid in Sun Yat-sen Univ. Daan): One of the earliest Chinese molecular diagnostics companies, with deep hospital penetration in Southern China and a broad PCR-based pathogen detection menu. Competes with Kunpeng in Chinese hospital and CDC channels for qPCR instruments and infectious-disease kits, particularly HPV, HBV, and respiratory pathogens.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/rocgene-technology-limited

Compliance15 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries2 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kunpeng Gene (Beijing) Scientific Instruments Co.